Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir

BACKGROUND: Severe anemia is a common side effect of Pegylated Interferon + Ribavirin (PR) and Telaprevir (TVR) in hepatitis C virus (HCV) genotype 1 patients with advanced fibrosis or cirrhosis (F3–F4). Inosine triphosphatase (ITPA) genetic variants are associated with RBV- induced anemia and dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghemo, Alessio, Grassi, Eleonora, Rumi, Maria Grazia, D'Ambrosio, Roberta, Galmozzi, Enrico, Degasperi, Elisabetta, Castaldi, Davide, Soffredini, Roberta, Colombo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997406/
https://www.ncbi.nlm.nih.gov/pubmed/24760000
http://dx.doi.org/10.1371/journal.pone.0095881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997406/
https://www.ncbi.nlm.nih.gov/pubmed/24760000
http://dx.doi.org/10.1371/journal.pone.0095881

Ejemplares similares